Semantic search

Jump to navigation Jump to search
 Issue dateTitleTopic
ML22326A10023 November 2022Approval of BWXT Medical Ltd. Request for Withholding Information from Public Disclosure of Canadian Nuclear Safety Commission (CNSC) Transport Certificate CDN/2094/B(U)-96, Revision 4, for the Model No. F-522
ML22286A04631 October 2022Application for the Model No. F-522 Transport Package - Supplemental Information Needed
ML22160A4248 June 2022AFFIDAVIT-Request for Validation Recommendation from the U.S. DOT, Package No. F-522, Certificate No. CDN2094B(U)-96, Revision 4 (Docket No. 71-3091)
ML22160A42116 May 2022Letter from R. Boyle (DOT) to Dfm Director (NRC) Request for Validation Recommendation from the U.S. DOT, Package No. F-522, Certificate No. CDN/2094/B(U)-96, Revision 4 (Docket No. 71-3091)
ML22160A42212 May 2022Letter from S. Lacasse (BWXT Medical) to R. Boyle (DOT) Request for Validation Recommendation from the U.S. DOT, Package No. F-522, Certificate No. CDN/2094/B(U)-96, Revision 4 (Docket No. 71-3091)
ML20034F1216 February 2020Letter-F-522 Revalidation
ML19344C20210 December 2019Acknowledgment Letter to DOT for F-522 Review
ML18213A01830 July 2018Letter to R. Boyle Review of Department of Transportation'S Submittal for Revalidation of the Canadian Competent Authority Certificate of Approval No. CDN/2094/B(U)-96, Revision 1, Model No. F-522-Withholding of Information from Public Disc
ML18208A26026 July 2018Letter to R. Boyle Certificate of Approval No. CDN/2094/B(U)-96, Revision 1, for the Model No. F-522 Package Dkt. No. 71-3091 (W/Enclosure 1)Hydrostatic